Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy

N/AUnknownNCT02067195

Guangdong Provincial People's Hospital560 enrolled

Overview

To compare the efficacy of 2 different hydration strategies, hydration according to clinical guideline and adequate hydration, on contrast-induced nephropathy in patients with STEMI undergoing primary PCI to investigate the possible beneficial role of periprocedural adequate hydration.

all consecutive patients with STEMI，age at least 18 years, who were candidates for primary PCI at our institution were considered for enrollment in the present study. Initial exclusion criteria were contrast medium administration within the previous 14 days, end-stage renal failure requiring dialysis, and refusal to give informed consent. Eligible patients were randomly assigned in a 1:1 ratio to receive preprocedure and postprocedure hydration (adequate hydration group), hydration according to clinical guideline (guideline hydration group，control group )

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

560

Conditions

ST Elevation Myocardial Infarction

Interventions

Receiving hydration with a 1 mL/kg bolus of intravenous isotonic saline (0.9% sodium chloride)DRUG

No hydration for patients without chronic kidney disease(CrCl\<60ml/min),or Receiving hydration with a 1 mL/kg bolus of intravenous isotonic saline (0.9% sodium chloride) after diagnosis of chronic kidney disease until 24 hours after PCI. Hydration rate was reduced to 0.5 mL/kg per hour in patients with New York Heart Association class III or KillipⅡ/Ⅲ.

3 mL/kg.hour bolus of intravenous isotonic saline (0.9% sodium chloride)DRUG

Receiving hydration with a 3 mL/kg.hour bolus of intravenous isotonic saline (0.9% sodium chloride) from randomization to the end of the procedure, the measurement of LVEDP was conducted after the procedure, a sliding-scale hydration was employed in the LVEDP-guided hydration arm that was based on LVEDP for 2 hours: 5 ml/kg/hr for LVEDP \<13 mmHg, 3 ml/kg/hr for LVEDP 13-18 mmHg, and \>1.5 ml/kg/hr for LVEDP \>18 mmHg, whereas,0.5 ml/kg/hr for LVEDP \>20 mmHg, continue hydration with a 1 mL/kg until 24 hours after procedure. Hydration rate was reduced to 0.5 mL/kg per hour in patients with New York Heart Association class III or KillipⅡ/Ⅲ.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all consecutive patients with STEMI, age at least 18 years, who were candidates for primary PCI were considered for enrollment. Exclusion Criteria: * contrast medium administration within the previous 14 days or follow 72 hours, * end-stage renal failure or renal transplantation, and refuse PCI or dead during the procedure, * heart failure of cardiac shock or New York Heart Association class IV, * recent acute kidney injury defined as an absolute increase of 0.5 mg/dl in serum creatinine over baseline in the past 24h * ,the presence of lactation, pregnancy, * malignant tumour or life expectancy less than 1 year, * allergy to contrast, peri-procedural receipt of metformin non-steroidalanti-inflammatory drugs in the past 48h and during the study period, * planned renal catheterization or heart valvular surgery。

Locations (1)

Guangdong General Hospital

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

Contrast-Induced Nephropathy

defined as a greater than 25% or an absolute increase of 0.5 mg/dl in serum creatinine over baseline during the first 48- 72 h post-procedure

Time frame: 72 hours

Contrast Induced Acute Kidney Injury

defined as a greater than 10% or an absolute increase of 0.3mg/dl in serum Cystatin C over baseline during the first 24 h post-procedure.

Time frame: 24 hours

Secondary Outcomes

contrast-induced acute kidney injury

defined as a greater than 50% or an absolute increase of 0.3 mg/dl in serum creatinine over baseline during the first 48h post-procedure

Time frame: 48 hours

Composite contrast-induced acute kidney injury

Defined as an absolute increase of 0.3 mg/dl in serum creatinine over baseline during the first 48h post-procedure and as a greater than 10% in Cystatin C over baseline during the first 24h post-procedure

Time frame: 48 hours

Persistent renal damage

Defined as a residual impairment of renal function indicated by a reduction of creatinine clearance more than 25% at 3 months in comparison with baseline

Time frame: 3 months

Alteration of renal function

defined as the alteration of creatinine clearance and estimated glomerular filtration rate (GFR) by using Cystatin C over baseline during the first 48- 72 h post-procedure

Time frame: 72 hours

Severe adverse renal events

Including contrast-induced nephropathy requiring renal replacement therapy and death caused by contrast-induced nephropathy

Central Contacts

Jiyan Chen, MD

CONTACT

86-20-83827812 chenjiyandr@126.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.